Difference between revisions of "Clinical Applications and Biological Targets Subcommittee"
Jump to navigation
Jump to search
m (→2013) |
|||
| Line 16: | Line 16: | ||
==2013== | ==2013== | ||
| + | |||
| + | *[[Media:03 18 2013 QIBA US SWS Clinical Applications-DRAFT.pdf |03.18.2013 QIBA US SWS Subcommittee: Clinical Applications Call Summary]] | ||
*[[Media:02 25 2013 QIBA US SWS Clinical Applications-DRAFT.pdf |02.25.2013 QIBA US SWS Subcommittee: Clinical Applications Call Summary]] | *[[Media:02 25 2013 QIBA US SWS Clinical Applications-DRAFT.pdf |02.25.2013 QIBA US SWS Subcommittee: Clinical Applications Call Summary]] | ||
Revision as of 19:25, 22 April 2013
Draft Charge
Reference Materials
Presentations and Reports
- SWS measurement(s) as biomarker(s) of Liver Fibrosis: Towards a Shared Vision - Claude Cohen-Bacrie, MS 25-February-2013
Call Summaries
2013
- 03.18.2013 QIBA US SWS Subcommittee: Clinical Applications Call Summary
- 02.25.2013 QIBA US SWS Subcommittee: Clinical Applications Call Summary
2012
- 12.17.2012 QIBA US SWS Subcommittee: Clinical Applications Call Summary
- 11.09.2012 QIBA US SWS Subcommittee: Clinical Applications Call Summary
- 10.22.2012 QIBA US SWS Subcommittee: Clinical Applications Call Summary - DC
- 10.01.2012 QIBA US SWS Subcommittee: Clinical Applications Call Summary
- 09.10.2012 QIBA US SWS Subcommittee: Clinical Applications Call Summary
- 08.13.2012 QIBA US SWS Subcommittee: Clinical Applications Call Summary
- 07.23.2012 QIBA US SWS Subcommittee: Clinical Applications Call Summary